Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007385
Filing Date
2019-05-15
Accepted
2019-05-15 16:06:29
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 815729
2 ex31-1.htm EX-31.1 19455
3 ex31-2.htm EX-31.2 19645
4 ex32-1.htm EX-32.1 7492
5 ex32-2.htm EX-32.2 7844
  Complete submission text file 0001493152-19-007385.txt   4279028

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE heb-20190331.xml EX-101.INS 704674
7 XBRL SCHEMA FILE heb-20190331.xsd EX-101.SCH 63788
8 XBRL CALCULATION FILE heb-20190331_cal.xml EX-101.CAL 61043
9 XBRL DEFINITION FILE heb-20190331_def.xml EX-101.DEF 206648
10 XBRL LABEL FILE heb-20190331_lab.xml EX-101.LAB 400307
11 XBRL PRESENTATION FILE heb-20190331_pre.xml EX-101.PRE 265361
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 19828037
SIC: 2836 Biological Products, (No Diagnostic Substances)